v3.25.3
FINANCIAL INCOME, NET
12 Months Ended
Jul. 31, 2025
Other Income and Expenses [Abstract]  
FINANCIAL INCOME, NET

NOTE 13: FINANCIAL INCOME, NET

 

   2025   2024 
   Year ended July 31, 
   2025   2024 
Interest income  $119,958   $288,018 
Unrealized gain on short-term investments   

56,473

    

-

 
Interest Expense   (36,979)   - 
Foreign exchange gain (loss)   (24,941)   (25,452)
Financial income (expenses), net  $114,511   $262,566 

 

 

BriaCell Therapeutics Corp

Notes to the Consolidated Financial Statements

For the Years Ended July 31, 2025 and 2024

(Expressed in US Dollars, except share and per share data and unless otherwise indicated)